Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patientsMauricette Michallet, Isabelle Jaisson‐Hot, Youcef Chelghoum et al.|Cancer|2012Cited by 17
Erythropoietin Use In Patients with AML or Undergoing Allogeneic HSCT Significantly Improves Quality of Life and Reduces Red Blood Cells and Platelets Transfusions without Any Survival Effect.Mauricette Michallet, Isabelle Jaisson‐Hot, Karine Goldet et al.|Blood|2010Cited by 0